Table 2.
Authors | Journal and Year | Design of the Trial | Patients | Endpoints | Main Findings |
---|---|---|---|---|---|
Rios-Fernandez et al. [36] | Clin. Exp. Rheumatol., 2012 | Case-control | 100 SSc vs. 100 control | Prevalence of osteopenia/osteoporosis among SSc patients and controls; association of vit D levels with clinical manifestations of SSc |
SSc patients had a higher prevalence of osteopenia and osteoporosis; vit D levels are associated with calcinosis, heart involvement, DLCO, and ANA positivity |
Ibn Yacoub et al. [37] | Rheumatol. Int., 2012 | Case-control | 60 SSc patients vs. 60 age and gender-matched controls | Comparison of the BMD in women with SSc and controls; the relationship between vit D status and disease parameters and BMD | BMD was significantly lower in SSc patients than in controls; in multiple regression models, there were significant correlations between BMD and longer duration of SSc, severe joint involvement, malabsorption syndrome, and the positivity of anti-DNA topoisomerase I antibodies; Vitamin D levels were correlated with the severity of joint pain, with anti-DNA topoisomerase I positivity and with BMD in the lumbar spine and femoral neck |
Atteritano et al. [38] | PloS ONE, 2013 | Case-control | 54 postmenopausal women with SSc and 54 postmenopausal controls | Comparison of BMD in SS patients and healthy controls; the prevalence of vertebral fractures | BMD at the lumbar spine, femoral neck, and total femur and ultrasound parameters at calcaneus were significantly lower in SSc patients, with a higher prevalence of vertebral fractures; SSc patients had a lower vit D plasma concentration, which was inversely related to BMD |
Corrado et al. [39] | PloS ONE, 2015 | Case-control | 64 SSc vs. 35 healthy controls | Evaluations of BMD, BMI, and vit D levels in two skin subsets (limited or diffuse) of SSc patients | BMD is significantly lower in dcSSc than in lcSSc and healthy controls; Vit D serum levels are higher in healthy controls than in SSc patients; among them, those affected by dcSSc showed lower levels than those with lcSSc in dcSSc (p < 0.001); vit D levels are not associated with internal organ involvement |
Sampaio-Barros et al. [40] | Rev. Bras. Reumatol., 2016 | Cross-sectional | 38 diffuse SSc patients | Correlation of vit D levels with organ involvement, antibody profile, BMD, results of questionnaires assessing the quality of life, nailfold capillaroscopy findings | Vit D levels were not correlated with organ involvement; vit d was lower in Scl-70+ subjects (p = 0.039); vit D levels were negatively correlated with quality of life, BMD and capillaroscopy findings |
Kamal et al. [41] | Immunol. Inves., 2016 | Case-control | 30 SSc patients and 60 healthy subjects | Evaluation of the potential association of VDR gene polymorphisms ApaI, and TaqI with SSc susceptibility in the Egyptian population. | No significant association of VDR ApaI and TaqI polymorphisms with SSc susceptibility |
Atteritano et al. [42] | Int. J. Mol. Sci., 2016 | Case-control | 40 SSc patients vs. 40 healthy control | Assess the prevalence of vitamin D insufficiency and correlation with clinical parameters in SSc |
Lower vitamin D levels were found in SSc patients vs healthy control. Skin involvement and pulmonary hypertension were associated with vitamin D deficiency |
Groseanu et al. [43] | Eur. J. Rheumatol. | Cross-sectional | 51 SSc patients | Evaluation of vitamin D concentration in SSc patients and its possible association with clinical manifestations | High prevalence of hypovitaminosis D (only 9.8% of subjects reached satisfactory levels); no correlation between vitamin D concentration and autoantibody profile, the extent of skin involvement; direct correlation of vitamin D with the DLCO, diastolic dysfunction, digital contractures, and muscle weakness |
Trombetta et al. [44] | PloS ONE, 2017 | Retrospective cohort | 154 SSc patients | Evaluation of possible correlations between vit D concentration and clinical manifestations | Vit D plasma levels were similar among patients with different clinical phenotypes and autoantibody positivity; vit. D concentrations were lower in those with bibasal fibrotic changes at lung CT scan |
Giuggioli et al. [45] | Clin. Rheumatol., 2017 | Cross sectional |
140 SSc patients, 49 supplemented and 91 not supplemented | Evaluation of possible correlations between vit D supplementation and clinical manifestations | SSc patients undergoing vit D supplementation showed higher vit D plasma levels, a lower prevalence of autoimmune thyroiditis, and a higher frequency of anticentromere antibodies |
Park et al. [46] | Clin. Rheumatol., 2017 | Case-control | 40 SSc women vs. 80 healthy controls | Investigate the association of vit D deficiency with digital ulcers (DUs), carotid intima-media thickness and brachial-ankle pulse wave velocity |
Vit D deficiency was an independent risk factor for DUs development, while it was not associated with atherosclerosis or arterial stiffness |
Zhang et al. [47] | Int. J. Rheum. Dis., 2017 | Case-control | 60 SSc vs. 60 healthy controls | Evaluation of vit D serum levels in SSc patients and healthy controls; evaluation of the potential association between vit. D and clinical features | Serum vit D levels were significantly lower in SSc patients, with no associations with clinical features of the disease |
Ahmadi et al. [48] | Iran. J. Public Health, 2017 | Case-control | 60 SSc patients vs. 30 healthy controls | Comparison of serum Klotho, FGF-23, and 25-hydroxy vit D levels in the SSc patients and healthy controls. | Serum Klotho and vit D concentrations are significantly lower in SSc patients than in the control group; no significant difference in FGF-23 levels between groups |
Hajialilo et al. [49] | Rheumatol. Int., 2017 | Case-control | 60 SSc patients vs. 60 healthy controls | Comparison of serum ET-1, α-Klotho, and vit D levels in patients with lcSSc and dcSSc scleroderma compared to healthy subjects | ET-1 was higher in SSc patients, while α-Klotho and 25(OH)D3 were lower in patients; Vit D levels were not associated with a specific autoantibody pattern |
Kotyla et al. [50] | J. Clin. Med., 2018 | Case-control | 48 SSc patients vs. 23 healthy controls | Assessment of the levels of vit D, α-Klotho, and FGF23 in SSc patients; association with clinical features | Vit D levels are lower in SSc patients. Vit D was not associated with the extent of skin involvement or disease severity |
Gupta et al. [51] | Indian Dermatol. Online J., 2018 | Case-control | 38 SSc patients vs. 38 health controls | Evaluation of vit D levels in SSc, in comparison to healthy controls and association with the extent of skin involvement | Vit D levels were lower in SSc patients and inversely associated with skin involvement assessed by the modified Rodnan skin score |
Li et al. [52] | Arch. Med. Res., 2019 | Case-control | 100 SSc patients and 100 healthy controls | Evaluation of the potential association of eight VDR gene polymorphisms ApaI, and TaqI with SSc susceptibility | ApaI and BglI polymorphism genotypes were significantly associated with the risk of SSc. |
Caimmi et al. [53] | Int. J. Rheum. Dis., 2019 | Retrospective cohort | 65 SSc patients | Evaluation of the association between vit D levels variation over time and development of DUs | The reduction of vit D level was correlated with an increased risk of developing DUs |
Horvath et al. [54] | Arthritis Res. Ther., 2019 | Case-control | 44 SSc patients vs. 33 healthy controls | Evaluation of bone alterations in SSc | BMD measured at the femoral neck and lumbar spine was lower in SSc patients than in controls; hypovitaminosis D was more frequent in SSc patients (60%) than in controls (39.3%; p = 0.003) |
Hax et al. [55] | J. Clin. Rheumatol., 2020 | Case-control | 50 SSc patients vs. 35 healthy controls | Evaluation of the correlation between serum levels of vit D and cytokines concentrations in SSc | Despite a more frequent vit D supplementation, SSc patients showed lower vit D levels; vit D plasma concentration was not correlated with cytokine profile |
Runowska et al. [56] | Reumatologia, 2021 | Retrospective cohort | 112 patients with connective tissue disease; 44 with SSc | Evaluation of hypovitaminosis D prevalence among rheumatic diseases patients | Hypovitaminosis D is highly prevalent in SSc patients, despite vitamin D supplementation |